Concepedia

Stuart B. Rosenblum

SB

Statistics

Publications

31

Citations

1.2K

H-Index

18

Active since

1985

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

WuXi AppTec (China)

Ligand Pharmaceuticals (United States)

United States Military Academy

Boehringer Ingelheim (United States)

Stuart B. Rosenblum is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicinal chemistry, drug discovery, and pharmacology.

Publications per year

1985–2018

31

Publications

31

Discovery of 1-(4-Fluorophenyl)-(3<i>R</i>)-[3-(4-fluorophenyl)-(3<i>S</i>)- hydroxypropyl]-(4<i>S</i>)-(4-hydroxyphenyl)-2-azetidinone (SCH 58235):  A Designed, Potent, Orally Active Inhibitor of Cholesterol Absorption

Stuart B. Rosenblum, Tram Huynh, Adriano Afonso et al. · Journal of Medicinal Chemistry · 1998 · 355 citations

, , +11

A selective and potent CXCR3 antagonist SCH 546738 attenuates the development of autoimmune diseases and delays graft rejection

Chung‐Her Jenh, Mary Ann Cox, Long Cui et al. · BMC Immunology · 2012 · 84 citations · Full text

, , +17

A selective and potent CXCR3 antagonist SCH 546738 attenuates the development of autoimmune diseases and delays graft rejection

Chung‐Her Jenh, Mary Ann Cox, Long Cui et al. · BMC Immunology · 2012 · 83 citations · Full text

, , +17

CCR2 and CXCR4 regulate peripheral blood monocyte pharmacodynamics and link to efficacy in experimental autoimmune encephalomyelitis

Yuanfan Wang, Long Cui, Waldemar Gonsiorek et al. · Journal of Inflammation · 2009 · 55 citations · Full text

, , +17

I. Novel HCV NS5B polymerase inhibitors: Discovery of indole 2-carboxylic acids with C3-heterocycles

G. Anilkumar, Charles A. Lesburg, Oleg Selyutin et al. · Bioorganic & Medicinal Chemistry Letters · 2011 · 49 citations

, , +14

1–5 of 31